HK1201873A1 - Derivation of neural stem cells and dopaminergic neurons from human pluripotent stem cells - Google Patents

Derivation of neural stem cells and dopaminergic neurons from human pluripotent stem cells

Info

Publication number
HK1201873A1
HK1201873A1 HK15102321.9A HK15102321A HK1201873A1 HK 1201873 A1 HK1201873 A1 HK 1201873A1 HK 15102321 A HK15102321 A HK 15102321A HK 1201873 A1 HK1201873 A1 HK 1201873A1
Authority
HK
Hong Kong
Prior art keywords
stem cells
derivation
human pluripotent
dopaminergic neurons
pluripotent stem
Prior art date
Application number
HK15102321.9A
Other languages
English (en)
Chinese (zh)
Inventor
Rodolfo Gonzalez
Ibon Garitaonandia
Ruslan Semechkin
Original Assignee
Int Stem Cell Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Int Stem Cell Corp filed Critical Int Stem Cell Corp
Publication of HK1201873A1 publication Critical patent/HK1201873A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/119—Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases (EC 2.)
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
HK15102321.9A 2012-04-24 2015-03-06 Derivation of neural stem cells and dopaminergic neurons from human pluripotent stem cells HK1201873A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261637797P 2012-04-24 2012-04-24
US201261637784P 2012-04-24 2012-04-24
PCT/US2013/037860 WO2013163228A1 (fr) 2012-04-24 2013-04-23 Obtention de cellules souches neuronales et de neurones dopaminergiques à partir de cellules souches pluripotentes humaines

Publications (1)

Publication Number Publication Date
HK1201873A1 true HK1201873A1 (en) 2015-09-11

Family

ID=49483836

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15102321.9A HK1201873A1 (en) 2012-04-24 2015-03-06 Derivation of neural stem cells and dopaminergic neurons from human pluripotent stem cells

Country Status (13)

Country Link
US (1) US9926529B2 (fr)
EP (1) EP2841566B1 (fr)
JP (1) JP6262205B2 (fr)
KR (1) KR20150004834A (fr)
CN (1) CN104379732B (fr)
AU (1) AU2013251749B2 (fr)
CA (1) CA2871337C (fr)
HK (1) HK1201873A1 (fr)
IL (1) IL235109B (fr)
MX (1) MX368315B (fr)
RU (1) RU2014147015A (fr)
SG (2) SG11201406825WA (fr)
WO (1) WO2013163228A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010096496A2 (fr) 2009-02-17 2010-08-26 Memorial Sloan-Kettering Cancer Center Procédés de conversion neurale de cellules souches embryonnaires humaines
PT2773748T (pt) 2011-11-04 2020-03-26 Memorial Sloan Kettering Cancer Center Neurónios dopaminérgicos (da) do mesencéfalo para enxerto
EP2961277A4 (fr) * 2013-02-15 2016-12-28 Int Stem Cell Corp Utilisation de neurones issus de céllules souches pluripotentes humaines pour le traitement de maladies neurodégénératives
EP3498824A1 (fr) 2013-04-26 2019-06-19 Memorial Sloan-Kettering Cancer Center Interneurones corticaux et autres cellules neuronales produits par la différentiation dirigée de cellules pluripotentes et multipotentes
EP3183338B1 (fr) 2014-08-19 2020-03-04 FUJIFILM Cellular Dynamics, Inc. Réseaux neuronaux formés à partir de cellules issues de cellules souches pluripotentes
EP3313420B1 (fr) 2015-06-25 2024-03-13 The Children's Medical Center Corporation Procédés et compositions se rapportant à l'expansion, l'enrichissement et la conservation de cellules souches hématopoïétiques
LU92845B1 (en) * 2015-10-08 2017-05-02 Univ Du Luxembourg Campus Belval Means and methods for generating midbrain organoids
EP3430132A4 (fr) * 2016-03-14 2019-12-25 Agency for Science, Technology and Research Génération d'organoïdes spécifiques du mésencéphale à partir de cellules souches pluripotentes humaines
EP3429603B1 (fr) 2016-03-15 2021-12-29 Children's Medical Center Corporation Procédés et compositions concernant l'expansion de cellules souches hématopoïétiques
US11702630B2 (en) 2016-05-31 2023-07-18 The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone In vitro methods of differentiating stem cells into neurons and neurons generated using the same
KR20200046099A (ko) * 2017-09-07 2020-05-06 메모리얼 슬로안 케터링 캔서 센터 줄기 세포-유도 외배엽 계통 전구체의 분화 방법
JP2019106895A (ja) 2017-12-15 2019-07-04 インダストリー‐ユニバーシティー コーぺレーション ファンデーション ハンヤン ユニバーシティ 神経幹細胞または神経前駆細胞からドーパミン神経細胞への分化方法
CN108559726A (zh) * 2017-12-28 2018-09-21 上海安集协康生物技术股份有限公司 一种对脑损伤类疾病有治疗作用的细胞亚群及其制备方法
KR102119148B1 (ko) * 2018-03-08 2020-06-04 고려대학교 산학협력단 신경조직 오가노이드의 제조방법, 이를 이용한 신경조직 형성 억제 물질의 스크리닝 방법 및 운동신경세포의 제조방법
TW202117009A (zh) * 2019-07-05 2021-05-01 丹麥商諾佛 儂迪克股份有限公司 衍生自人類富潛能幹細胞的神經幹細胞株的製備方法
CN110432888B (zh) * 2019-08-15 2021-11-23 任鹏宇 一种前庭神经权重信息编码神经元的筛选方法
WO2021054806A1 (fr) * 2019-09-20 2021-03-25 한국생명공학연구원 Procédé de production de progéniteurs neuronaux dopaminergiques induits par reprogrammation directe
JP2023503302A (ja) * 2019-11-22 2023-01-27 ノヴォ ノルディスク アー／エス スピン凝集した神経系マイクロスフェアおよびその応用
JP2021084882A (ja) * 2019-11-28 2021-06-03 学校法人慶應義塾 脊髄損傷治療用ニューロスフェア誘導剤及びその使用
CN111269887B (zh) * 2020-02-28 2021-11-16 上海市东方医院（同济大学附属东方医院） 一种人多能干细胞向外胚层分化的方法
CA3226992A1 (fr) * 2021-07-19 2023-01-26 Trailhead Biosystems Inc. Procedes et compositions pour generer des cellules progenitrices neurales du cerveau humain
CA3231278A1 (fr) 2021-09-10 2023-03-16 Deepika Rajesh Compositions de cellules derivees de cellules souches pluripotentes induites et leurs procedes d'utilisation
AU2022376962A1 (en) 2021-10-29 2024-04-18 FUJIFILM Cellular Dynamics, Inc. Dopaminergic neurons comprising mutations and methods of use thereof
CN114292807A (zh) * 2021-12-28 2022-04-08 深圳市夏同生物医药科技有限公司 一种外泌体的提取方法及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453357A (en) 1992-10-08 1995-09-26 Vanderbilt University Pluripotential embryonic stem cells and methods of making same
US5690926A (en) 1992-10-08 1997-11-25 Vanderbilt University Pluripotential embryonic cells and methods of making same
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US6251671B1 (en) 1996-02-28 2001-06-26 Vanderbilt University Compositions and methods of making embryonic stem cells
EP1441737B1 (fr) * 2001-10-30 2006-08-09 Novartis AG Derives de staurosporine inhibiteurs de l'activite tyrosine kinase du recepteur flt3
US8158420B2 (en) * 2003-04-04 2012-04-17 The Trustees Of Columbia University In The City Of New York Methods for inhibiting the differentation of proliferative telencephalic cells in vitro by addition of ATF5
US20090291134A1 (en) * 2006-11-21 2009-11-26 Jina Pharmaceuticals, Inc. Endoxifen methods and compositions in the treatment of psychiatric and neurodegenerative diseases
US20110136145A1 (en) 2008-05-22 2011-06-09 The Johns Hopkins University Methods for promoting fusion and reprogramming of somatic cells
ES2590036T3 (es) * 2009-08-12 2016-11-17 Kyoto University Método para inducir la diferenciación de células madre pluripotentes en células precursoras neurales
KR101168053B1 (ko) 2009-11-06 2012-07-24 연세대학교 산학협력단 효율적이고 보편적인 전분화능 줄기세포의 신경세포 분화 유도방법
US9376664B2 (en) * 2010-06-14 2016-06-28 The Scripps Research Institute Reprogramming of cells to a new fate

Also Published As

Publication number Publication date
CA2871337A1 (fr) 2013-10-31
EP2841566A4 (fr) 2015-12-23
RU2014147015A (ru) 2016-06-10
US20150087541A1 (en) 2015-03-26
EP2841566B1 (fr) 2019-03-13
IL235109B (en) 2020-05-31
WO2013163228A1 (fr) 2013-10-31
JP6262205B2 (ja) 2018-01-17
US9926529B2 (en) 2018-03-27
CN104379732A (zh) 2015-02-25
AU2013251749B2 (en) 2019-01-17
MX2014013054A (es) 2016-12-20
JP2015514437A (ja) 2015-05-21
CN104379732B (zh) 2018-08-17
MX368315B (es) 2019-09-27
SG11201406825WA (en) 2014-11-27
IL235109A0 (en) 2014-12-31
CA2871337C (fr) 2021-04-20
AU2013251749A1 (en) 2014-11-13
EP2841566A1 (fr) 2015-03-04
SG10201608838QA (en) 2016-12-29
KR20150004834A (ko) 2015-01-13

Similar Documents

Publication Publication Date Title
HK1201873A1 (en) Derivation of neural stem cells and dopaminergic neurons from human pluripotent stem cells
HK1218927A1 (zh) 人類多能幹細胞在限定條件下進行血液內皮分化的方法和材料
SG11201803043VA (en) Derivation of human skin organoids from pluripotent stem cells
HK1205203A1 (en) Methods and processes for non-invasive assessment of genetic variations
HK1215358A1 (zh) 由人多能幹細胞衍生的神經細胞在治療神經退行性疾病上的用途
HK1207885A1 (en) Differentiation of human embryonic stem cells into pancreatic endoderm
EP2640403A4 (fr) Génération de cellules souches neurales à partir de cellules souches trophoblastiques humaines
IL260824A (en) Differentiation of human pluripotent stem cells into cortical neurons
EP2909313A4 (fr) Production de globules rouges et de plaquettes à partir de cellules souches
EP2658966A4 (fr) Différenciation de cellules souches pluripotentes humaines en cellules de crête neurale multipotente
EP2925863A4 (fr) Cellules souches cardiaques et leurs procédés d'identification et d'utilisation
EP2861224A4 (fr) Nanoparticules d'épinéphrine, procédé pour les fabriquer et procédés pour les utiliser pour le traitement d'affections répondant à l'épinéphrine
EP3555262A4 (fr) Production et utilisations thérapeutiques de cellules pluripotentes d'epinul et cellules différenciées dérivées de celles-ci
IL244808A0 (en) Direct differentiation of astrocytes from human pluripotent stem cells for use in drug screening and treatment of amyotrophic lateral sclerosis (ALS)
EP2814947A4 (fr) Profil phénotypique de cellules progénitrices humaines de la rétine
IL260380B1 (en) Induction of differentiation from human pluripotent stem cells into hypothalamic neurons
IL237887A0 (en) Devices and methods for encouraging hair growth
HK1208249A1 (en) Method of extracting neural stem cells using nanoparticles
IL274995A (en) Stem cells extracted from brown fat and their use
EP2849712A4 (fr) Procédés et dispositifs d'application d'une stimulation mécanique au corps
HK1223967A1 (zh) 人誘導多能幹細胞衍生的心肌細胞的內向整流的電子表達
EP2911748A4 (fr) Vaccination et traitement de cellule souche cancéreuse
HK1243648A1 (zh) 利用神經幹細胞與il12p40增强神經再生的方法
SG11201406771PA (en) Stem cell preparations and methods of use
GB201322323D0 (en) Differentiation of human epidermal neural crest stem cells (hEPI-NCSC) into virtually homogenous populations of dopaminergic neurons